Centres de soins tertiaires : Questions médicales fréquentes
Nom anglais: Tertiary Care Centers
Descriptor UI:D062606
Tree Number:N02.278.421.830
Termes MeSH sélectionnés :
Polymorphism, Genetic
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Centres de soins tertiaires : Questions médicales les plus fréquentes",
"headline": "Centres de soins tertiaires : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Centres de soins tertiaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-05",
"dateModified": "2025-04-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Centres de soins tertiaires"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hôpitaux",
"url": "https://questionsmedicales.fr/mesh/D006761",
"about": {
"@type": "MedicalCondition",
"name": "Hôpitaux",
"code": {
"@type": "MedicalCode",
"code": "D006761",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N02.278.421"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Centres de soins tertiaires",
"alternateName": "Tertiary Care Centers",
"code": {
"@type": "MedicalCode",
"code": "D062606",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Wanda Lam",
"url": "https://questionsmedicales.fr/author/Wanda%20Lam",
"affiliation": {
"@type": "Organization",
"name": "Department of Surgery, University Hospitals Cleveland Medical Center, 11000 Euclid Avenue, Lakeside 7th Floor, Cleveland, OH, 44106, USA. wanda.lam@uhhospitals.org."
}
},
{
"@type": "Person",
"name": "Gi Yoon Kim",
"url": "https://questionsmedicales.fr/author/Gi%20Yoon%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Surgery, University Hospitals Cleveland Medical Center, 11000 Euclid Avenue, Lakeside 7th Floor, Cleveland, OH, 44106, USA."
}
},
{
"@type": "Person",
"name": "Clayton Petro",
"url": "https://questionsmedicales.fr/author/Clayton%20Petro",
"affiliation": {
"@type": "Organization",
"name": "Department of Surgery, University Hospitals Cleveland Medical Center, 11000 Euclid Avenue, Lakeside 7th Floor, Cleveland, OH, 44106, USA."
}
},
{
"@type": "Person",
"name": "Adel Alhaj Saleh",
"url": "https://questionsmedicales.fr/author/Adel%20Alhaj%20Saleh",
"affiliation": {
"@type": "Organization",
"name": "Department of Surgery, University Hospitals Cleveland Medical Center, 11000 Euclid Avenue, Lakeside 7th Floor, Cleveland, OH, 44106, USA."
}
},
{
"@type": "Person",
"name": "Leena Khaitan",
"url": "https://questionsmedicales.fr/author/Leena%20Khaitan",
"affiliation": {
"@type": "Organization",
"name": "Department of Surgery, University Hospitals Cleveland Medical Center, 11000 Euclid Avenue, Lakeside 7th Floor, Cleveland, OH, 44106, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "HMOX1 genetic polymorphisms and outcomes in infectious disease: A systematic review.",
"datePublished": "2022-05-12",
"url": "https://questionsmedicales.fr/article/35551540",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0267399"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genetic polymorphism of Y-chromosome in Kazakh populations from Southern Kazakhstan.",
"datePublished": "2023-10-27",
"url": "https://questionsmedicales.fr/article/37891458",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12864-023-09753-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tardive Dyskinesia Development, Superoxide Dismutase Levels, and Relevant Genetic Polymorphisms.",
"datePublished": "2022-10-28",
"url": "https://questionsmedicales.fr/article/36338339",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/5748924"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Analysis of Genetic Polymorphism on Mitochondrial Hypervariable Region III in Thai Population.",
"datePublished": "2023-03-09",
"url": "https://questionsmedicales.fr/article/36980954",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/genes14030682"
}
},
{
"@type": "ScholarlyArticle",
"name": "Investigating genetic polymorphism in E. histolytica isolates with distinct clinical phenotypes.",
"datePublished": "2023-08-29",
"url": "https://questionsmedicales.fr/article/37642770",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00436-023-07952-x"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Établissements, main d'oeuvre et services de soins de santé",
"item": "https://questionsmedicales.fr/mesh/D005159"
},
{
"@type": "ListItem",
"position": 3,
"name": "Établissements de santé",
"item": "https://questionsmedicales.fr/mesh/D006268"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hôpitaux",
"item": "https://questionsmedicales.fr/mesh/D006761"
},
{
"@type": "ListItem",
"position": 5,
"name": "Centres de soins tertiaires",
"item": "https://questionsmedicales.fr/mesh/D062606"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Centres de soins tertiaires - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Centres de soins tertiaires",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Centres de soins tertiaires",
"description": "Comment sont diagnostiquées les maladies complexes ?\nQuels tests sont utilisés en soins tertiaires ?\nQuel rôle joue la génétique dans le diagnostic ?\nComment les consultations multidisciplinaires aident-elles ?\nQu'est-ce qu'un diagnostic différentiel ?",
"url": "https://questionsmedicales.fr/mesh/D062606?mesh_terms=Polymorphism,+Genetic&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Centres de soins tertiaires",
"description": "Quels symptômes nécessitent un soin tertiaire ?\nComment reconnaître une urgence médicale ?\nLes symptômes varient-ils selon les spécialités ?\nQuels symptômes sont liés aux maladies rares ?\nComment les symptômes évoluent-ils dans le temps ?",
"url": "https://questionsmedicales.fr/mesh/D062606?mesh_terms=Polymorphism,+Genetic&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Centres de soins tertiaires",
"description": "Comment prévenir les maladies complexes ?\nQuel rôle joue l'éducation à la santé ?\nLes vaccinations sont-elles importantes ?\nComment le dépistage précoce aide-t-il ?\nQuels conseils de mode de vie peuvent aider ?",
"url": "https://questionsmedicales.fr/mesh/D062606?mesh_terms=Polymorphism,+Genetic&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Centres de soins tertiaires",
"description": "Quels traitements sont offerts en soins tertiaires ?\nComment les traitements sont-ils personnalisés ?\nQuel est le rôle des essais cliniques ?\nComment la réhabilitation est-elle intégrée ?\nQuels traitements sont utilisés pour les maladies chroniques ?",
"url": "https://questionsmedicales.fr/mesh/D062606?mesh_terms=Polymorphism,+Genetic&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Centres de soins tertiaires",
"description": "Quelles sont les complications possibles des traitements ?\nComment gérer les complications ?\nLes complications sont-elles prévisibles ?\nQuel impact les complications ont-elles sur le patient ?\nComment les complications influencent-elles le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D062606?mesh_terms=Polymorphism,+Genetic&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Centres de soins tertiaires",
"description": "Quels sont les facteurs de risque des maladies complexes ?\nComment l'environnement influence-t-il la santé ?\nLe mode de vie affecte-t-il les risques ?\nLes antécédents familiaux sont-ils importants ?\nComment le stress impacte-t-il la santé ?",
"url": "https://questionsmedicales.fr/mesh/D062606?mesh_terms=Polymorphism,+Genetic&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment sont diagnostiquées les maladies complexes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les maladies complexes sont diagnostiquées par des tests spécialisés, imageries et consultations multidisciplinaires."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés en soins tertiaires ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests avancés comme l'IRM, la biopsie et les tests génétiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la génétique dans le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La génétique aide à identifier des maladies héréditaires et à personnaliser les traitements."
}
},
{
"@type": "Question",
"name": "Comment les consultations multidisciplinaires aident-elles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles permettent d'obtenir des avis d'experts de différentes spécialités pour un diagnostic précis."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'un diagnostic différentiel ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est le processus d'élimination d'autres maladies ayant des symptômes similaires."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un soin tertiaire ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes graves ou persistants comme des douleurs intenses, des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une urgence médicale ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la difficulté à respirer, la perte de conscience ou des douleurs thoraciques."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les spécialités ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque spécialité peut présenter des symptômes spécifiques selon les pathologies traitées."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux maladies rares ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes atypiques ou non spécifiques, souvent mal compris ou mal diagnostiqués."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils dans le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent s'aggraver, se stabiliser ou s'améliorer selon le traitement et la maladie."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies complexes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par des dépistages réguliers, un mode de vie sain et des vaccinations."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'éducation à la santé ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation à la santé informe les patients sur les risques et les comportements à adopter."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles protègent contre certaines maladies graves et réduisent les complications."
}
},
{
"@type": "Question",
"name": "Comment le dépistage précoce aide-t-il ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il permet de détecter les maladies à un stade précoce, augmentant les chances de traitement efficace."
}
},
{
"@type": "Question",
"name": "Quels conseils de mode de vie peuvent aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter une alimentation équilibrée, faire de l'exercice et éviter le tabac et l'alcool."
}
},
{
"@type": "Question",
"name": "Quels traitements sont offerts en soins tertiaires ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements avancés comme la chirurgie spécialisée, la chimiothérapie et la radiothérapie."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils personnalisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont adaptés selon le profil génétique et les caractéristiques spécifiques du patient."
}
},
{
"@type": "Question",
"name": "Quel est le rôle des essais cliniques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les essais cliniques testent de nouveaux traitements et améliorent les options disponibles."
}
},
{
"@type": "Question",
"name": "Comment la réhabilitation est-elle intégrée ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réhabilitation est essentielle pour aider les patients à retrouver leur autonomie après un traitement."
}
},
{
"@type": "Question",
"name": "Quels traitements sont utilisés pour les maladies chroniques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements à long terme comme les médicaments, la thérapie physique et le suivi régulier."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des traitements ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des infections, des effets secondaires et des rechutes."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion implique un suivi régulier, des ajustements de traitement et un soutien psychologique."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être anticipées, d'autres surviennent de manière imprévisible."
}
},
{
"@type": "Question",
"name": "Quel impact les complications ont-elles sur le patient ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent affecter la qualité de vie, nécessiter des soins supplémentaires et prolonger la maladie."
}
},
{
"@type": "Question",
"name": "Comment les complications influencent-elles le traitement ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent nécessiter des modifications du traitement initial pour éviter des risques supplémentaires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des maladies complexes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hérédité, l'âge, le mode de vie et certaines conditions médicales."
}
},
{
"@type": "Question",
"name": "Comment l'environnement influence-t-il la santé ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition à des toxines, la pollution et le stress peuvent augmenter le risque de maladies."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il les risques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme le tabagisme, l'inactivité physique et une mauvaise alimentation augmentent les risques."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils importants ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies peuvent indiquer un risque accru pour les individus."
}
},
{
"@type": "Question",
"name": "Comment le stress impacte-t-il la santé ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut affaiblir le système immunitaire et augmenter le risque de maladies."
}
}
]
}
]
}
Heme-oxygenase 1 (HMOX1) is a critical stress response gene that catalyzes the multistep oxidation of heme. A GT(n) repeat of variable length in the promoter in has been associated with a wide range o...
A search using relevant terms was performed in PubMED and EMBASE through to 15/01/21 identifying all research that studied an association between the HMOX1 GT(n) repeat polymorphism and the incidence ...
1,533 studies were identified in the search, and one via citation screening. Sixteen studies were ultimately included, seven in malaria, three in HIV, three in sepsis, and one each in pneumonia, hepat...
Despite the importance of HMOX1 in survival from infection, and the association between repeat length and gene expression, the clinical data supporting an association between repeat length and inciden...
The Kazakhs are one of the biggest Turkic-speaking ethnic groups, controlling vast swaths of land from the Altai to the Caspian Sea. In terms of area, Kazakhstan is ranked ninth in the world. Northern...
The Kazakhstan Y-chromosome Haplotype Reference Database was expanded with 468 Kazakh males from the Zhambyl and Turkestan regions of South Kazakhstan by having their 27 Y-STR loci and 23 Y-SNP marker...
The Kazakhstan Y-chromosome Haplotype Reference Database was formed for 27 Y-STR loci with a total sample of 1796 samples of Kazakhs from 16 regions of Kazakhstan. The variability of the Y-chromosome ...
Tardive dyskinesia (TD) is a prevalent movement disorder that significantly impacts patients with schizophrenia (SCZ) due to extended exposure to antipsychotics (AP). Several genetic polymorphisms, in...
Mitochondrial DNA (mtDNA) analysis is a genetic marker for human identification, especially matrilineal inheritance. Hypervariable regions (HVR) I and II of mtDNA have been currently performed for hum...
Amoebiasis is an infection caused by enteric protozoa, most commonly Entamoeba histolytica, and is globally considered a potentially severe and life-threatening condition. To understand the impact of ...
Occupational exposure to toluene causes serious health problems ranging from drowsiness to lethal diseases such as cancer. Paint workers are exposed to toluene through inhalation or the dermal route, ...
First, we included skilled paint workers (n = 30) as exposed and healthy individuals (n = 30) as control belonging to the same socio-economic strata. The genotoxicity biomarkers, Cytokinesis-block mic...
A significantly higher frequency of CBMN (4.43 ± 1.50) and tail moment (TM) (11.23 ± 1.0) respectively in paint workers as compared to the control(1.50 ± 0.86 and (0.54 ± 0.37) underlined significantl...
Overall, our study provides a strong rationale for identifying a clear association between glutathione-S-transferase polymorphism and genetic damage in paint workers....
To identify, critically evaluate and synthesize the evidence obtained from systematic reviews on the association between genetic polymorphisms and osteoarthritis (OA) development....
Considering gene polymorphisms associated with OA susceptibility (risk or protection), a comprehensive search was conducted in the following databases, without date or language restrictions: MEDLINE, ...
We included 14 systematic reviews of case-control studies comparing individuals with a radiographic diagnosis of all OA types and healthy controls, all submitted to the genetic examination of differen...
Based on low-quality to critically-low-quality systematic reviews, some gene polymorphisms seem to be associated with risk or protection for OA. Further high-quality studies are needed to validate the...
Tolperisone, a muscle relaxant used for post-stroke spasticity, is metabolized to its main metabolite by CYP2D6 and to a lesser extent by CYP2C19 and CYP1A2. We investigated the effects of CYP2D6 and ...
Silicosis is a pneumoconiosis characterized by fibrosis of the lung parenchyma caused by inhalation of silica particles. Genetic factors might play a role in the severity silicosis. We sought to evalu...
Nine polymorphisms were genotyped by PCR in a sample of 143 patients with silicosis in the state of Rio de Janeiro, Brazil....
Fifty-seven patients (40%) were classified as having simple silicosis and 86 (60%) were classified as having complicated silicosis. The TT genotype of rs1800469 in the TGFB1 gene showed a protective e...
It appears that rs1800469 polymorphisms in the TGFB1 gene and rs763110 polymorphisms in the FASLG gene are involved in the severity of silicosis. Given the lack of studies relating genetic polymorphis...
Many pharmacokinetic studies of lacosamide (LCM) have been reported, but no large-scale clinical study has been conducted on genetic polymorphisms that affect the metabolism of LCM. Therefore, we desi...
Adult patients with epilepsy who received LCM at Seoul National University Hospital were enrolled. Blood samples were obtained from 115 patients taking LCM for more than 1 month with unchanged doses a...
The serum LCM concentration showed a linear correlation with the daily dose (r = .66, p < .001). In genetic analysis, 43 patients (38.7%) were extensive metabolizers (EMs), 51 (45.9%) were intermediat...
Genetic polymorphisms of the CYP2C19 gene affect the serum LCM concentration. Because efficacy and toxicity are apparently related to serum LCM levels, the genetic phenotype of CYP2C19 should be consi...